Home
 

InvestorGuide Stock Analysis

Dow Chemical to Sell Newly Acquired Morton Salt
Excerpt from the InvestorGuide.com Stock of the Day on 4/2/2009

Less than twenty four hours after Dow Chemical (DOW: Charts, News, Offers) announced its successful $15 billion acquisition of Rohm & Haas. The chemical firm has already divested one of its newly acquired subsidiaries, Morton Salt. Dow sold Morton Salt today to the German based K+S Aktiengesellschaft for $1.675 billion. Although many market analysts believe that the deal was fair for both parties involved. Why would Dow Chemical sell a business that earns a yearly revenue of $1.2 billion so quickly?

Well for starters, Dow did not have much of a choice. As part of the agreement to acquire Rohm and Haas, Dow Chemical agreed to sell off the Morton Salt subsidiary. It is true that Dow was steered to these terms unexpectedly. However, the chemical giant would not have agreed to such a contingency without its reasons. As with most business decisions, the primary factor behind Dow's choice was money. More >


Subscribe to the Stock of the Day!
 

Add to tracker

InvestorGuide Stock of the Day RSS feed

RSS
DOW Chemical: Slapped with a "No."
Excerpt from the InvestorGuide.com Stock of the Day on 12/29/2008

In pre-market trading, Dow Chemical & Rohm & Haas (ROH: Charts, News, Offers) were hit hard when news came in that the proposed joint venture between DOW and Kuwait's state-owned Petrochemical Industries failed. Even though the price for this joint venture was renegotiated about a week and a half ago, Kuwait still declined. While both parties would have benefited from this deal, Kuwait did state that this was an overpriced arrangement. Is "overpriced" the whole picture? Does this mean Kuwaiti funds are completely out of the picture? And what are the options available to Dow to acquire Rohm & Haas if they do not have Kuwaiti funds to apply to an acquisition? More >

Dow Chemical Buys Rohm & Haas
Excerpt from the InvestorGuide.com Stock of the Day on 7/10/2008

The Dow Chemical Company (DOW: Charts, News, Offers) makes a big splash in the chemical industry today with its purchase of the Rohm & Haas Company (ROH: Charts, News, Offers). Dow Chemical announced this morning that it will buy Rohm & Haas for an estimated $15.3 billion in an all-cash deal. Stockholders of Rohm & Haas will receive $78 for each share they hold, resulting in a 74% mark up from the closing price yesterday. So, why has the biggest U.S. chemical producer decided to pay a premium price for Rohm & Haas? More >

"True energy crisis" Forces Dow Chemical to Raise Prices
Excerpt from the InvestorGuide.com Stock of the Day on 5/28/2008

Desperate times call for desperate measures. The current state of the U.S. economy is apparently forcing Dow Chemical to make a major decision in order to stay afloat and its customers will not be pleased. Like many other American companies, Dow has been faced with rising costs to produce its goods and now company leaders have announced details of how they plan to cope. Their plans call for a drastic increase in prices to help offset costs, but will Dow's customers embrace the change so that the new strategy has a chance to work? More >

Dow Chemical Climbs on Leveraged Buyout Rumors   4/9/2007

Dow Chemical's Higher Prices Lead to Increased Revenue   10/26/2006

Dow Chemical Company (DOW) Upgrades

Date
Analyst
Old Rating
New Rating
05/11/2009
Credit Suisse
Neutral
Outperform
02/11/2009
Gilford Securities
Hold
Buy
06/05/2007
Lehman Brothers
Equal-Weight
Overweight
03/12/2007
Lehman Brothers
Equal Weight
Underweight
02/26/2007
Merrill Lynch
Neutral
Sell
05/16/2006
J.P. Morgan
Overweight
Neutral

Dow Chemical Company (DOW) Downgrades

Date
Analyst
Old Rating
New Rating
09/16/2009
Standpoint Research
Buy
Hold
12/29/2008
Barclay's Capital
Overweight
Equalweight
07/10/2008
BB&T
Buy
Hold
08/05/2007
Matrix Research
Strong Buy
Buy
08/04/2007
Matrix Research
Strong Buy
Buy
08/03/2007
Matrix Research
Strong Buy
Buy

Dow Chemical Company (DOW) New Coverage

Date
Analyst
Rating
07/29/2009
UBS
Buy
01/27/2009
Credit Suisse
Neutral
Get Analysis For: